Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2022, European Heart Journal
Transplantation, 2016
Interactive Cardiovascular and Thoracic Surgery, 2019
The Journal of Heart and Lung Transplantation, 2011
Journal of Cardiac Failure, 2023
Interactive CardioVascular and Thoracic Surgery, 2019
Summary A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether heart transplantation is a viable treatment option in patients in refractory cardiogenic shock who could not be weaned off venoarterial extracorporeal membrane oxygenation (VA ECMO). Altogether, 373 papers were found using the reported search, of which 7 papers represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Evidence is derived from 3 papers based on registry analysis, 1 multi-institutional study and 3 single-institution reviews. Early post-transplant mortality of ECMO-bridged recipients ranges from 18.7% to 33.3% and 1-year survival from 44.6% to 72.0%. High acuity of recipient illness reflected by poor renal function, mechanical ventilation, advanced age, elevated serum lactate predict in...
European Journal of Cardio-Thoracic Surgery, 2011
Artificial organs, 2016
Early graft failure (EGF) is a major risk factor for death after heart transplantation (Htx). We investigated the predictive risk factors for moderate-to-severe EGF requiring an intra-aortic balloon pump (IABP) or extracorporeal membrane oxygenation (ECMO) circulatory support as treatment after Htx. Between January 2000 and December 2014, 412 consecutive adult patients underwent isolated Htx at our institution. Moderate and severe EGF were defined as the need for IABP and ECMO support, respectively, within 24 h after Htx. All available recipient and donor variables were analyzed to assess the risk of EGF occurrence. Overall, moderate-to-severe EGF occurred in 46 (11.1%) patients. Twenty-nine (63.04%) patients required peripheral or central ECMO support in the treatment of severe EGF and 17 (36.9%) patients required IABP support for the treatment of moderate EGF. The predictive risk factors for moderate-to-severe EGF in recipients, as assessed by logistic regression analysis, were a ...
InTech eBooks, 2016
Annals of cardiothoracic surgery, 2019
Advanced Applications in Extracorporeal Membrane Oxygenation [Working Title]
E-Journal of Tourism, 2019
Aziatische Kunst, 2010
Vittor Carpaccio, Gentile Bellini e gli altri. Venezia, luoghi, prospettive tra realtà e invenzione, 2024
The Gospel of John: The Hypothetical Original Text Restored and Translated, 2024
Review of Evolutionary Political Economy, 2024
JUSTIMES (Jurnal Rekayasa Teknik Mesin Saburai)
Anuarul Institutului de Cercetări Socio-Umane „C S Nicolăescu-Plopșor”, 2023
University of Tehran, 2024
Nature Immunology, 2020
Archives de Pédiatrie, 2010